535 related articles for article (PubMed ID: 23972041)
1. Screening for type 2 diabetes: a short report for the National Screening Committee.
Waugh NR; Shyangdan D; Taylor-Phillips S; Suri G; Hall B
Health Technol Assess; 2013 Aug; 17(35):1-90. PubMed ID: 23972041
[TBL] [Abstract][Full Text] [Related]
2. Screening for type 2 diabetes: literature review and economic modelling.
Waugh N; Scotland G; McNamee P; Gillett M; Brennan A; Goyder E; Williams R; John A
Health Technol Assess; 2007 May; 11(17):iii-iv, ix-xi, 1-125. PubMed ID: 17462167
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.
Webb DR; Khunti K; Srinivasan B; Gray LJ; Taub N; Campbell S; Barnett J; Henson J; Hiles S; Farooqi A; Griffin SJ; Wareham NJ; Davies MJ
Trials; 2010 Feb; 11():16. PubMed ID: 20170482
[TBL] [Abstract][Full Text] [Related]
4. Assessment of glucose metabolism in polycystic ovary syndrome: HbA1c or fasting glucose compared with the oral glucose tolerance test as a screening method.
Lerchbaum E; Schwetz V; Giuliani A; Obermayer-Pietsch B
Hum Reprod; 2013 Sep; 28(9):2537-44. PubMed ID: 23756702
[TBL] [Abstract][Full Text] [Related]
5. Pharmacy Diabetes Screening Trial: protocol for a pragmatic cluster-randomised controlled trial to compare three screening methods for undiagnosed type 2 diabetes in Australian community pharmacy.
Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Namara KM
BMJ Open; 2017 Dec; 7(12):e017725. PubMed ID: 29284715
[TBL] [Abstract][Full Text] [Related]
6. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.
Simmons RK; Borch-Johnsen K; Lauritzen T; Rutten GE; Sandbæk A; van den Donk M; Black JA; Tao L; Wilson EC; Davies MJ; Khunti K; Sharp SJ; Wareham NJ; Griffin SJ
Health Technol Assess; 2016 Aug; 20(64):1-86. PubMed ID: 27583404
[TBL] [Abstract][Full Text] [Related]
7. How are we diagnosing cardiometabolic risk in primary care settings?
Gohdes D; Amundson H; Oser CS; Helgerson SD; Harwell TS
Prim Care Diabetes; 2009 Feb; 3(1):29-35. PubMed ID: 19155195
[TBL] [Abstract][Full Text] [Related]
8. Glycated hemoglobin A1c as a screening test for detecting type 2 diabetes mellitus in obese children and adolescents.
Yoon JS; So CH; Lee HS; Hwang JS
J Pediatr Endocrinol Metab; 2018 Apr; 31(5):503-506. PubMed ID: 29652667
[TBL] [Abstract][Full Text] [Related]
9. Screening obese children and adolescents for prediabetes and/or type 2 diabetes in pediatric practices: a validation study.
Brar PC; Mengwall L; Franklin BH; Fierman AH
Clin Pediatr (Phila); 2014 Jul; 53(8):771-6. PubMed ID: 24671874
[TBL] [Abstract][Full Text] [Related]
10. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.
Simmons RK; Echouffo-Tcheugui JB; Sharp SJ; Sargeant LA; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
Lancet; 2012 Nov; 380(9855):1741-8. PubMed ID: 23040422
[TBL] [Abstract][Full Text] [Related]
11. Let's prevent diabetes: study protocol for a cluster randomised controlled trial of an educational intervention in a multi-ethnic UK population with screen detected impaired glucose regulation.
Gray LJ; Khunti K; Williams S; Goldby S; Troughton J; Yates T; Gray A; Davies MJ;
Cardiovasc Diabetol; 2012 May; 11():56. PubMed ID: 22607160
[TBL] [Abstract][Full Text] [Related]
12. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
13. Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
Ollila MM; West S; Keinänen-Kiukaanniemi S; Jokelainen J; Auvinen J; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen LC
Hum Reprod; 2017 Feb; 32(2):423-431. PubMed ID: 28031324
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions.
Barry E; Roberts S; Oke J; Vijayaraghavan S; Normansell R; Greenhalgh T
BMJ; 2017 Jan; 356():i6538. PubMed ID: 28052845
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study.
Gillett M; Brennan A; Watson P; Khunti K; Davies M; Mostafa S; Gray LJ
Health Technol Assess; 2015 May; 19(33):1-80. PubMed ID: 25947106
[TBL] [Abstract][Full Text] [Related]
16. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Prediabetes and Undiagnosed Diabetes in Canada (2007-2011) According to Fasting Plasma Glucose and HbA1c Screening Criteria.
Rosella LC; Lebenbaum M; Fitzpatrick T; Zuk A; Booth GL
Diabetes Care; 2015 Jul; 38(7):1299-305. PubMed ID: 25852207
[TBL] [Abstract][Full Text] [Related]
18. Comparison of glycated haemoglobin and fasting blood glucose in the diagnosis of diabetes mellitus and pre-diabetes in a cohort of obese patients.
Chan DML; Murphy M
J R Nav Med Serv; 2017; 103(1):39-43. PubMed ID: 30088739
[TBL] [Abstract][Full Text] [Related]
19. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India-Outcome of screening.
Priscilla S; Nanditha A; Simon M; Satheesh K; Kumar S; Shetty AS; Snehalatha C; Johnston DG; Godsland IF; Wareham NJ; Ramachandran A
Diabetes Res Clin Pract; 2015 Dec; 110(3):335-40. PubMed ID: 26547503
[TBL] [Abstract][Full Text] [Related]
20. Screening for type 2 diabetes and dysglycemia.
Echouffo-Tcheugui JB; Ali MK; Griffin SJ; Narayan KM
Epidemiol Rev; 2011; 33():63-87. PubMed ID: 21624961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
